Skip to main content
Signal8

AULIN SHERRY

SEC insider (Form 3/4/5 filer). CIK 0001862144. Chief Financial Officer at Xenon Pharmaceuticals Inc. (XENE). 6 reported Form 4/5 transactions since Sep 2024; latest on Dec 18, 2024. Located in BURNABY, A1.

Companies AULIN SHERRY has filed insider reports for

  • Xenon Pharmaceuticals Inc. (XENE): Officer, Chief Financial Officer
AULIN SHERRY profile photo

AULIN SHERRY

CIK: 0001862144

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Xenon Pharmaceuticals Inc. logo
XENE

Xenon Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Xenon Pharmaceuticals Inc. logo
    XENE

    Xenon Pharmaceuticals Inc.

    Dec 18, 2024
    Exercise
    Direct
    9.3K shares at avg. $9.44$88K
  • Xenon Pharmaceuticals Inc. logo
    XENE

    Xenon Pharmaceuticals Inc.

    Dec 18, 2024
    Tax Payment
    Direct
    2.1K shares at avg. $41.28$88K
  • Xenon Pharmaceuticals Inc. logo
    XENE

    Xenon Pharmaceuticals Inc.

    Dec 18, 2024
    Sale
    Direct
    7.2K shares at avg. $41.23$297K
  • Xenon Pharmaceuticals Inc. logo
    XENE

    Xenon Pharmaceuticals Inc.

    Dec 18, 2024
    Exercise
    Direct
    16K shares at avg. $11.58$185K
  • Xenon Pharmaceuticals Inc. logo
    XENE

    Xenon Pharmaceuticals Inc.

    Dec 18, 2024
    Tax Payment
    Direct
    4.5K shares at avg. $41.28$185K
  • Xenon Pharmaceuticals Inc. logo
    XENE

    Xenon Pharmaceuticals Inc.

    Dec 18, 2024
    Sale
    Direct
    11.5K shares at avg. $41.19$474K

1-6 of 6